Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA 2019-12-11 22:00
GemVax announced phase II results of GV1001 for Alzheimer's disease treatment at CTAD 2019 2019-12-11 18:40
Xinhua Silk Road: E. China Nanjing Jiangbei New Area aims to develop life and health industry 2019-12-11 16:52
CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST 2019-12-11 11:00
AGC Biologics Expands Plasmid DNA Offering 2019-12-11 09:06
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma 2019-12-11 08:41
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting 2019-12-10 16:00
CStone's anti-PD-L1 antibody demonstrates promising antitumor activity with a complete response rate of 33.3% and a good safety profile in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma 2019-12-10 11:38
Townsville Hospital Treats First Australian Patient With Elekta Unity MR-Linac, a Transformative Approach to Precision Radiation Therapy 2019-12-10 08:13
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies 2019-12-09 22:00
Hebron Announces $6.5 Million Private Placement 2019-12-09 21:30
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors 2019-12-09 21:00
CStone appoints seasoned pharmaceutical executive Shirley Zhao as the General Manager for Greater China and Head of Commercial 2019-12-06 18:53
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-LAG-3 Monoclonal Antibody in China 2019-12-06 08:00
Suvoda Secures $40M Investment from LLR Partners 2019-12-05 17:00
Mayapada Clinic Accomplished Plenary Level Certification from the Accreditation Commission of the Ministry of Health 2019-12-05 13:17
Biocon Biologics Takes Forward its Mission to Unlock Universal Access to Insulins Globally 2019-12-05 09:00
FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa 2019-12-04 19:22
Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China 2019-12-04 12:57
Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US 2019-12-03 17:36
1 310 311 312 313 314 412